Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 Years' experience

Scandinavian Journal of Rheumatology

Volumn 36, Issue 6, 2007, Pages 452-457

  Wildt, M ^a   Hesselstrand, R ^a   Akesson A ^a   Scheja, A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CAPILLARY DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FINGER; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MORPHEA; NAIL; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAPILLARIES; CELL COUNT; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NAILS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 37349100455     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701483030     Document Type: Article

References (26)

1. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by 'wide-field' microscopy. Arthritis Rheum 1973;6:619-28.
2. Maricq HR, LeRoy EC, D'Angelo WA, Medsger TA Jr, Rodnadn GP, Sharp GC, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980;23:183-9.
3. Maricq HR, Weinberger AB, LeRoy EC. Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy. J Rheumatol 1982;9:289-91.
4. Lee P, Leung F, Alderdice C, Armstrong S. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 1983;10:930-8.
5. Statham BN, Rowell NR. Quantification of the nailfold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Acta Derm Venereol (Stockholm) 1986;66:139-43.
6. Ohtsukua T. Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases. Int J Dermatol 1999;38:757-64.
7. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment or microvascular damage in systemic sclerosis. J Rheumatol 2000;1:155-60.
8. Houtman P, Kallenberg C, Fiedler V, Wouda A. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. J Rheumatol 1986;13:556-63.
9. Zufferey P, Depairon M, Chamot A-M, Monti M. Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 1992;11:536-41.
10. Maricq HR, Spencer-green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976;61:862-70.
11. Harper FE, Maricq HWR, Turner RE, Lidman R, Leroy EC. A prospective study of Raynaud's phenomenon and early connective tissue disease. Am J Med 1982;72:883-8.
12. Luggen M, Belhorn L, Evans T, Fitzgerald O, Spencer-Green G. The evolution of Raynaud's phenomenon: a longterm prospective study. J Rheumatol 1995;22:2226-32.
13. Andersson ME, Allen PD, Moore T, Hillier V, Taylor CJ, Herrick AL. Computerized nailfold video capillaroscopy - a new tool for assessment of Raynaud's phenomenon. J Rheumatol 2005;32:841-8.
14. Wildt M, Hesselstrand R, Scheja A, Åkesson A. Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis. Clin Exp Rheumatol 1999;17:219-22.
15. Scheja A, Åkesson A, Niewierowicz I, Wallin L, Wildt M, Wollheim FA. Computer-based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 1996;55:52-6.
16. Krutzen E, Bäck SE, Nilsson-Ehle I, Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol: a method for assessment of glomerular filtration rate. J Lab Clin Med 1984;104:955-61.
17. Clements PJ, Lachenbruch P, Seibold JR, Zee B, Steen VD, Brennan P, et al. Inter- and intraobserver variability of total skin thickness score (modified Rodnad TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
18. Masi AT, Rodnan GP, Medsger TA Jr, Altman RD, D'Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
19. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
20. LeRoy C, Medsger T. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
21. Allcock RJ, Forrest I, Corris PA, Crook PR, Griffiths ID. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 2004;43:596-602.
22. Wollheim FA. Classification of systemic sclerosis. Visions and reality. J Reumatol 2005;44:1212-16.
23. Buckari M, Hollis S, Moore T, Jayson MIV, Herrick AL. Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology 2000;39:506-12.
24. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, et al. Nailfold video capillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004;43:719-26.
25. Bredemeier M, Xavier RM, Copobianco KG, Restelli VG, Rohde LEP, Pinotti AFF, et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004;31:286-94.
26. Lovy M, MacCarter D, Steigerwald J. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 1985;28:496-501.